Adverse events72

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 72

Type	Event	Organ system	Group	Affected	At risk
other	Eye disorders	Eye disorders	Fenofibrate 145 mg	2	576
other	Eye disorders	Eye disorders	Placebo Oral Tablet	2	575
other	Gastrointestinal disorders	Gastrointestinal disorders	Fenofibrate 145 mg	6	576
other	Gastrointestinal disorders	Gastrointestinal disorders	Placebo Oral Tablet	5	575
other	Hepatobiliary disorders	Hepatobiliary disorders	Fenofibrate 145 mg	0	576
other	Hepatobiliary disorders	Hepatobiliary disorders	Placebo Oral Tablet	1	575
other	Investigations	Investigations	Fenofibrate 145 mg	1	576
other	Investigations	Investigations	Placebo Oral Tablet	3	575
other	Musculoskeletal and connective tissue disorders	Musculoskeletal and connective tissue disorders	Fenofibrate 145 mg	3	576
other	Musculoskeletal and connective tissue disorders	Musculoskeletal and connective tissue disorders	Placebo Oral Tablet	2	575
other	Nervous system disorders	Nervous system disorders	Fenofibrate 145 mg	4	576
other	Nervous system disorders	Nervous system disorders	Placebo Oral Tablet	3	575
other	Pregnancy, puerperium and perinatal conditions	Pregnancy, puerperium and perinatal conditions	Fenofibrate 145 mg	0	576
other	Pregnancy, puerperium and perinatal conditions	Pregnancy, puerperium and perinatal conditions	Placebo Oral Tablet	1	575
other	Respiratory, thoracic and mediastinal disorders	Respiratory, thoracic and mediastinal disorders	Fenofibrate 145 mg	1	576
other	Respiratory, thoracic and mediastinal disorders	Respiratory, thoracic and mediastinal disorders	Placebo Oral Tablet	1	575
other	Skin and subcutaneous tissue disorders	Skin and subcutaneous tissue disorders	Fenofibrate 145 mg	0	576
other	Skin and subcutaneous tissue disorders	Skin and subcutaneous tissue disorders	Placebo Oral Tablet	3	575
serious	Blood and lymphatic system disorders	Blood and lymphatic system disorders	Fenofibrate 145 mg	5	576
serious	Blood and lymphatic system disorders	Blood and lymphatic system disorders	Placebo Oral Tablet	2	575

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03439345/events

API reference For AI assistants

Adverse events72

Sources 3

Read this list from software.